top of page

Mon, Jun 22

|

Webinar

PADCEV (enfortumab vedotin-eifv) approved treatment for locally advanced or mUC patients

A virtual program on an FDA approved treatment option in locally advanced or mUC for patients who have previously received a PD-1 or PD-L1 inhibitor and platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced, or metastatic setting.

Registration is Closed
See other events
PADCEV (enfortumab vedotin-eifv) approved treatment for locally advanced or mUC patients
PADCEV (enfortumab vedotin-eifv) approved treatment for locally advanced or mUC patients

Time & Location

Jun 22, 2020, 6:00 PM

Webinar

Guests

About The Event

Presented by Bethany Mooney, MSN, CRNP

Medical Oncology Nurse Practitioner

Penn Medicine

Philadelphia, PA

RSVP via the following link: https://vision2voiceevents.com/summer/program4

Share This Event

bottom of page